Radioembolization With Chemotherapy for Colorectal Liver Metastases: A Randomized, Open-Label, International, Multicenter, Phase III Trial

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2021) Hyuna Sung et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial

(2020) Chiara Cremolini et al.   LANCET ONCOLOGY

Yttrium‐90 radiation segmentectomy for hepatic metastases: A multi‐institutional study of safety and efficacy

(2020) Siddharth A. Padia et al.   JOURNAL OF SURGICAL ONCOLOGY

Distinguishable Prognostic Signatures of Left- and Right-Sided Colon Cancer: a Study Based on Sequencing Data

(2018) Liang Liang et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Effect of Primary Tumor Side on Survival Outcomes in Untreated Patients With Metastatic Colorectal Cancer When Selective Internal Radiation Therapy Is Added to Chemotherapy: Combined Analysis of Two Randomized Controlled Studies

(2018) Peter Gibbs et al.   Clinical Colorectal Cancer

Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer

(2017) Alan P. Venook et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Right Versus Left Colon Cancer Biology: Integrating the Consensus Molecular Subtypes

(2017) Michael S. Lee et al.   Journal of the National Comprehensive Cancer Network

Radioembolization of Hepatic Malignancies: Background, Quality Improvement Guidelines, and Future Directions

(2017) Siddharth A. Padia et al.   JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY

First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials

(2017) Harpreet S Wasan et al.   LANCET ONCOLOGY

Prognostic and Predictive Relevance of Primary Tumor Location in Patients With RAS Wild-Type Metastatic Colorectal Cancer

(2017) Sabine Tejpar et al.   JAMA Oncology

SIRFLOX: Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus Selective Internal Radiation Therapy in Patients With Metastatic Colorectal Cancer

(2016) Guy A. van Hazel et al.   JOURNAL OF CLINICAL ONCOLOGY

Statistical controversies in clinical research: end points other than overall survival are vital for regulatory approval of anticancer agents

(2015) E. D. Saad et al.   ANNALS OF ONCOLOGY

Outcomes of Therasphere Radioembolization for Colorectal Metastases

(2015) Andrea M. Abbott et al.   Clinical Colorectal Cancer

Location of colon cancer (right-sided versus left-sided) as a prognostic factor and a predictor of benefit from cetuximab in NCIC CO.17

(2015) S.Y. Brulé et al.   EUROPEAN JOURNAL OF CANCER

90Y Radioembolization of Colorectal Hepatic Metastases Using Glass Microspheres: Safety and Survival Outcomes from a 531-Patient Multicenter Study

(2015) R. Hickey et al.   JOURNAL OF NUCLEAR MEDICINE

Chemoradiation of Hepatic Malignancies: Prospective, Phase 1 Study of Full-Dose Capecitabine With Escalating Doses of Yttrium-90 Radioembolization

(2014) Ryan Hickey et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Patient and Tumor Characteristics and BRAF and KRAS Mutations in Colon Cancer, NCCTG/Alliance N0147

(2014) Wilson I. Gonsalves et al.   JNCI-Journal of the National Cancer Institute

Final results from a randomized phase 3 study of FOLFIRI ± panitumumab for second-line treatment of metastatic colorectal cancer

(2013) M. Peeters et al.   ANNALS OF ONCOLOGY

Comparison of RECIST and Choi criteria for computed tomographic response evaluation in patients with advanced gastrointestinal stromal tumor treated with sunitinib

(2011) O. Dudeck et al.   ANNALS OF ONCOLOGY

Radioembolization of colorectal hepatic metastases using yttrium-90 microspheres

(2009) Mary F. Mulcahy et al.   CANCER

Analysis of PTEN, BRAF, and EGFR Status in Determining Benefit From Cetuximab Therapy in Wild-Type KRAS Metastatic Colon Cancer

(2009) Pierre Laurent-Puig et al.   JOURNAL OF CLINICAL ONCOLOGY

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER